Eiger BioPharmaceuticals Lands $1,100,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b48bd8c6-d600-4135-ac15-399d5d4322b8 - Date
9/8/2014 - Company Name
Eiger BioPharmaceuticals - Mailing Address
1115 Lafayette St. Santa Clara, CA 95050 USA - Company Description
Eiger BioPharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. - Website
http://www.eigerbio.com - Transaction Type
Venture Equity - Transaction Amount
$1,100,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
